Safety and Effectiveness Study of OR3O™ Dual Mobility System in THA

Active, not recruitingOBSERVATIONAL
Enrollment

177

Participants

Timeline

Start Date

July 27, 2020

Primary Completion Date

December 31, 2026

Study Completion Date

January 31, 2035

Conditions
Advanced Degeneration of the Hip JointRevision of the Hip Joint
Interventions
DEVICE

Primary Total Hip Arthroplasty

Primary Total Hip Arthroplasty using the OR3O Dual Mobility System in combination with compatible components

DEVICE

Revision Total Hip Arthroplasty

Revision Total Hip Arthroplasty using the OR3O Dual Mobility System in combination with compatible components

Trial Locations (13)

2255

Queen Mary Hospital, Hong Kong

2600

Calvary John James Hospital, Deakin

4101

Mater Health Services, Brisbane

6000

Royal Perth Hospital, Perth

10003

NYU Langone Health, New York

10021

Hospital for Special Surgery, New York

27157

Wake Forest School of Medicine, Winston-Salem

40508

University of Kentucky, Lexington

69198

University of Nebraska Medical Center, Omaha

78705

St. David's Center for Hip and Knee Replacement, Austin

T3M127

South Health Campus, Calgary, Calgary

N6A 5A5

London Health Sciences Center Division of Orthopaedics, London

M5C1R6

St Michael's Hospital, Toronto

All Listed Sponsors
lead

Smith & Nephew, Inc.

INDUSTRY